📣 Let health ministers know you want timely access to the Novavax COVID-19 vaccine for the 2026/2027 season
✉️ Send letters to health ministers to voice your support for access to the Novavax COVID-19 vaccine in 2026/2027. Use our online tool to send emails.
Why take action? Sanofi Canada announced in April 2026 that the Health Canada-approved Novavax COVID-19 vaccine can be available to Canadians for the 2026/2027 season. However, concerns are mounting about whether provincial and territorial governments will in fact procure this world-leading vaccine in time.
Canadians have made it clear that they want access to the non-mRNA Novavax vaccine. The decision by governments to remove access to Novavax in Canada in fall 2024 and 2025 went against the advice of scientific experts, including the “Guidance on the use of COVID-19 vaccines for 2025 to summer 2026” by Canada’s National Advisory Committee on Immunization (NACI). In that guidance, NACI noted that the Pfizer and Moderna mRNA vaccines are not superior to the Novavax vaccine. It also noted that removing access to the Novavax vaccine — the only protein-based COVID-19 vaccine in Canada — could negatively affect vaccine uptake.
People across Canada, including many Canadians with disabilities and immunocompromised Canadians, rely on Novavax’s protein-based vaccine as it reduces the risk of adverse side effects to which they are disproportionately vulnerable. This includes people who have medical contraindications to the mRNA vaccines, for whom the Novavax vaccine is the only COVID-19 vaccine option.
Some Canadians are forced to travel to the United States to pay out of pocket for the Novavax vaccine due to the lack of access in Canada. However, this is beyond the reach of many disabled and lower-income people and becoming more difficult due to safety issues with travel to the United States. In February 2026, the Canadian Immunocompromised Advocacy Network released an open letter, signed by doctors and stakeholder organizations across Canada, recommending that Canadian governments restore access to the Novavax vaccine.
Please take a moment to voice your support for access to the Novavax vaccine in Canada!
- Make sure your email application is active (e.g. Mail or Thunderbird).
- Click a button in the contact list below. It will create a message using the message template.
- Customize your message. Don’t forget to add your name and email address, and modify the wording of the message if you like.
- Click the send button in your email software.
- Repeat — click the button for the next person in the list. It’s easy to go through the list, and send emails to health ministers. (⏰ Time: about 1-2 minutes).
Note: For best results, use an iPhone or another smartphone. If a message isn’t created when you click or tap a button, you can try using a different device. This won’t work with obsolete browsers such as Internet Explorer; use Firefox or Safari instead. Issues with Microsoft Outlook have been reported.
We need expanded COVID-19 vaccine choices
More information
To:
List of contacts
Cc:
- Marjorie Michel, Minister of Health, hcminister.ministresc@hc-sc.gc.ca
- Dr. Joss Reimer, Chief Public Health Officer, CPHOCorrespondence@phac-aspc.gc.ca
- Nancy Hamzawi, President, PHAC, nancy.hamzawi@phac-aspc.gc.ca
- Dr. Supriya Sharma, Chief Medical Advisor, Health Canada, supriya.sharma@hc-sc.gc.ca
Subject: Novavax now! We need access to the Novavax COVID-19 vaccine in 2026/2027!
Message template:
I am writing to request that you provide Canadians access to the non-mRNA Novavax COVID-19 vaccine in fall 2026 and going forward, in addition to the mRNA vaccines (Pfizer and Moderna). Novavax is a world-leading Health Canada-approved vaccine that was offered to Canadians up until 2024 and should be offered again.
According to Canada’s National Advisory Committee on Immunization (NACI), the mRNA-based vaccines (Pfizer and Moderna) are not superior to the Novavax protein-based vaccine. Lack of access to the Novavax vaccine — the only non-mRNA COVID-19 vaccine in Canada — could negatively affect vaccine uptake.[1]
People across Canada, including many Canadians with disabilities and immunocompromised Canadians, rely on the Novavax vaccine. This includes people who have medical contraindications to the mRNA vaccines, for whom the Novavax vaccine is the only COVID-19 vaccine option. These factors, among other reasons for restoring access to the vaccine, are detailed in an open letter released by the Canadian Immunocompromised Advocacy Network in February 2026.[2]
This is a safety and equity issue for Canadians — an issue that requires leadership on your part. Please ensure Canadians can access the Novavax COVID-19 vaccine in fall 2026 and beyond.
Notes: [1] National Advisory Committee on Immunization. “Guidance on the use of COVID-19 vaccines for 2025 to summer 2026”: https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-statement-guidance-covid-19-vaccines-2025-summer-2026.html. [2] Canadian Immunocompromised Advocacy Network. “Expanded COVID-19 Education and Vaccine Choices for all Canadians” (February 2026): https://immunocompromised.ca/accelerated-access-covid19/.
Sincerely,
[Your name and email address]